Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFAMYCIN vs RILONACEPT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIFAMYCIN vs RILONACEPT: Safety Overview

Metric RIFAMYCIN RILONACEPT
Total FAERS Reports 106 843
Deaths Reported 26 14
Death Rate 24.5% 1.7%
Hospitalizations 35 65
Average Patient Age 56.1 yrs 51.9 yrs
% Female Patients 54.5% 68.2%
FDA Approval Date Nov 16, 2018 N/A
Manufacturer N/A Kiniksa Pharmaceuticals (UK), Ltd.
Route N/A SUBCUTANEOUS
Marketing Status Discontinued Prescription